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northumbria.ac.ukAbstractThis study examined the agreement between fingertip-capillary and antecubital-venous
measures of appetite-related peptides. Simultaneous fingertip-capillary and antecubital-
venous blood samples were collected from 19 participants. The samples were obtained
at baseline, 30, 60, 90, and 120 min following breakfast for the determination of plasma
GLP17–36, glucagon, insulin and leptin. Between-day reproducibility of fingertip-capillary-
derived estimates was assessed in 18 participants. Deming regression, limits of agreement
(LOA) and typical error as a coefficient of variation (CV) were used to quantify agreement
(CVa) and reproducibility (CVr). Deming regression revealed no systematic bias for any of
the analytes studied, but for insulin there was evidence of a proportional difference at
higher concentrations. Measures of GLP17–36 (CVaZ24.0%, LOA G2.5 pg m/l per h), leptin
(CVaZ9.0%, LOA!/O1.19) and glucagon (CVaZ21.0%, LOA, G31.5 pg m/l per h) revealed
good agreement between methodological approaches. Fingertip-capillary glucagon was
highly reproducible between days (CVrZ8.2%). GLP17–36 and leptin demonstrated modest
reproducibility (CVrZ22.7 and 25.0% respectively). For insulin, agreement (CVaZ36.0%,
LOA !/O1.79) and reproducibility were poor (CVrZ36.0%). Collectively, the data
demonstrate that fingertip-capillary blood sampling provides a comparable and
reproducible alternative to antecubital-venous blood sampling for the quantification of
glucagon, and to a lesser extent for GLP17–36 and leptin. Caution should be exercised when
utilising fingertip-capillary blood sampling for insulin quantification, and consequently
should not be employed interchangeably with antecubital-venous blood sampling.Key Words
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.0 UEndocrine Connections
(2014) 3, 233–242IntroductionMultiple hormonal peptides involved in the regulation
of energy homeostasis are produced and secreted into
the circulation in response to the ingestion of a meal.
These peptides, emanating from the periphery of the
gastrointestinal tract, pancreas, and adipose, act to
influence the physiological mechanisms controlling
energy regulation, eliciting divergent actions on feedingbehaviour and metabolism (1). In humans, hormonal
peptides such as glucagon-like peptide-1 (GLP1) (2),
glucagon (3), insulin (4), and leptin (5), among others,
represent several commonly measured metabolic variables
documented as key effectors targeting energy intake and
expenditure. Accurate quantification of these peptides is
therefore essential when exploring hormonal responsessed under a Creative Commons
nported License.
Table 1 Participant characteristics by study.
Part 1 Part 2
Agreement
(nZ19)
Between-day
reproducibility (nZ18)
Mean S.D. Mean S.D.
Age (years) 24.1 5.7 23.1 3.5
Mass (kg) 73.7 10.9 69.3 12.7
Height (m) 1.8 0.1 1.7 0.1
BMI (kg/m2) 23.6 2.1 23.1 2.7
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2–10 3 :234in studies concerning appetite, feeding behaviour and
metabolism.
In clinical and research practice, quantitative
measures of appetite- and metabolism-related peptides
have commonly been assessed using venepuncture or
antecubital-venous catheterisation. Obtaining i.v. access
is often problematic in certain exercise (particularly
running) and field settings and with vulnerable popu-
lations, where alternative techniques for blood sampling
may be effective. Fingertip-capillary blood sampling offers
an alternative approach to venous sampling and may
help to overcome issues associated with venepuncture or
antecubital-venous catheterisation. Furthermore, the
nature of fingertip-capillary blood sampling poses numer-
ous advantages including simple application, reduced
ethical consideration and volume of blood required for
analysis (6). To date, only three studies have employed
fingertip-capillary blood sampling for quantification of
appetite- and metabolism-related peptides including
leptin, insulin, and GLP17–36 (7, 8, 9). Data from these
studies indicate that fingertip-capillary-derived measures
were representative of values reported from previous
research employing antecubital-venous sampling, and
begin to provide affirmation for the use of this approach
in energy-related research.
No evidence exists, however, confirming fingertip-
capillary-derived measures of appetite- and metabolism-
related peptides are reproducible, and accurately reflect
concentrations in comparison with their antecubital-
venous equivalents. The test–retest reproducibility of
these peptides is therefore essential, making certain that
an intervention(s) or variable(s) is responsible for any
observed differences and is not brought about by random
variability or measurement error (10, 11). Quantification
of agreement and reproducibility between methods would
facilitate appropriate comparisons between studies using
venous and capillary blood sampling. This is particularly
important given that blood obtained from different
sampling locations (e.g. antecubital-venous blood and
fingertip-capillary blood) is characteristically dissimilar.
Capillary blood, for example, encompasses an assortment
of blood from venules, arterioles, intracellular and inter-
stitial fluid and of course the capillaries. The quantity of
arterialised blood is more pronounced in capillary blood
compared with antecubital-venous blood, and is therefore
thought to be more reflective of arterial blood (12).
Accordingly, the aims of this study were twofold.
Firstly, the study was designed to examine the agreement
of GLP17–36, glucagon, insulin and leptin between
fingertip-capillary blood sampling and antecubital-venoushttp://www.endocrineconnections.org
DOI: 10.1530/EC-14-0110
 2014 The authors
Published by Bioscientifica Ltdblood sampling in a resting state (part 1). Secondly, this
study assessed the between-day test-retest reproducibility
(part 2) of the aforementioned peptides in a resting state
using fingertip-capillary blood sampling.Materials and methods
Participants
In total, 19 healthy adult participants (15 males and four
females) from the staff and student population of North-
umbria University at Newcastle upon Tyne participated
in part 1. Eighteen healthy adult participants (nine males
and nine females) participated in part 2 of this study.
Participant details are provided in Table 1. The partici-
pants were informed of the purpose, procedures and
potential risks of the study and written informed consent
was obtained from all before data collection. The study
was conducted according to the guidelines laid down in
the 2013 Declaration of Helsinki (13), and all procedures
involving human subjects were approved by the Faculty
of Health and Life Sciences Ethics Committee of the
University of Northumbria.Study design
In part 1, participants attended the laboratory on a
single occasion where simultaneous samples of fingertip-
capillary and antecubital-venous blood were collected to
assess the agreement between the measures of appetite-
and metabolism-related peptides. The samples were
obtained in the fasting and postprandial state for the
determination of plasma GLP17–36, glucagon, insulin and
leptin. For part 2, participants attended the laboratory
on two separate occasions separated by 7 days, where
fingertip-capillary blood was sampled to determine the
reproducibility of the aforementioned peptides. The
participants reported to the clinical testing laboratory at
designated times between 0700 and 0900 h, following aThis work is licensed under a Creative Commons
Attribution 3.0 Unported License.
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laboratory was documented and kept consistent between
successive trials (part 2 only). The participants were
instructed to refrain from the consumption of caffeine
and alcohol (R12 h) and strenuous physical activity
(R24 h) preceding data collection. Between waking and
arrival at the clinical testing laboratory, consumption of
water only was permitted. The participants were requested
to record, document and replicate morning water con-
sumption for subsequent trials. Following baseline (tZ0)
blood samples, participants were issued with a standar-
dised cereal and milk breakfast. Further samples of
antecubital-venous (part 1 only) and fingertip-capillary
blood were collected at 30, 60, 90, and 120 min during the
postprandial period. Additional food and beverage con-
sumption was prohibited until test termination, apart
from water that was offered ad libitum. In-trial ad libitum
fluid consumption (if any) was documented and matched
for subsequent trials. Throughout the test periods,
participants remained sedentary in an environment free
from food cues.Blood sampling
At five separate intervals, simultaneous fingertip-capillary
(0.3 ml) and antecubital-venous blood samples (8.0 ml)
were drawn into pre-cooled EDTA-treated microvettes and
monovettes respectively. The samples were collected at
baseline (tZ0 min) and at 30, 60, 90, and 120 min
following breakfast consumption for the determination
of plasma GLP17–36, glucagon, insulin and leptin. Venous
blood was drawn from an indwelling cannula (Venflon
20G, Becton Dickinson & Company, East Rutherford, NJ,
USA) inserted into an antecubital forearm vein. Patency
of the cannula was preserved by flushing a small volume
of non-heparinised saline (0.9% NaCl; Becton Dickinson &
Company) through the connector tube on completion of
each antecubital-venous sample. Residual saline waste was
discarded immediately before succeeding sample points,
avoiding contamination and dilution of antecubital-
venous blood. Fingertip-capillary blood was simul-
taneously obtained from a pre-warmed fingertip pierced
with a sterile automated lancet (Accu-Check, Mannheim,
Germany). Fingertip-capillary blood samples were also
collected for assessing reproducibility for part of the study.
Approximately 3–5 min preceding each fingertip-capillary
sample, the entire sample-hand was pre-warmed in warm
water to promote an adequate flow of fingertip-capillary
blood. On removal, the hand was dried thoroughly and
the identified site for puncture was further cleansedhttp://www.endocrineconnections.org
DOI: 10.1530/EC-14-0110
 2014 The authors
Published by Bioscientifica Ltdby wiping with an aseptic alcohol. On puncturing the
fingertip, the first drop of blood was removed before
subsequent collection, where care was taken not to apply
excessive pressure. All blood samples were obtained while
subjects lay in a semi-supine position.
Blood collection tubes contained aprotinin (33 ml/ml
blood) and a di-peptidyl peptidase IV inhibitor (30 ml/ml
blood) for the preservation of GLP17–36 and glucagon
by proteases. Sample pre-treatment and the addition of
protease inhibitors were applied to both microvettes and
monovettes and performed preceding sample collection.
Of note, the addition of protease inhibitors to plasma
samples for the preservation of GLP17–36 and glucagon
does not influence measured concentrations of plasma
leptin and insulin (14). Following collection, samples were
placed on ice and immediately centrifuged. The mono-
vettes were spun at 1509 g for 10 min at 4 8C in a
refrigerated multispeed centrifuge and microvettes spun
at 3000 r.p.m. for 10 min in a multispeed micro-
centrifuge. The aliquots of plasma supernatant were
housed in appropriately labelled eppendorfs and stored
at K80 8C for the determination of plasma GLP17–36,
glucagon, insulin and leptin concentrations.Breakfast meal
Following baseline measures, participants consumed a
standardised breakfast meal consisting of semi-skimmed
milk (Sainsbury, London, UK) and Kellogg’s Rice Krispies
(Kelloggs, Manchester, UK), distributed at a cereal-to-milk
ratio of 30 g: 125 ml. The quantity issued was designed to
provide 10% of the participants estimated daily energy
requirement for protein, fat and carbohydrate (14, 14, and
72% respectively) as previously used and drawn from
recommendations from the National Diet and Nutrition
Survey (15). Individual daily energy requirements were
computed according to age and sex-specific calculations
(16), providing an estimate of basal metabolic rate. The
estimated values of basal metabolic rate were further
multiplied against a self-perceived physical activity
factor. The participants were given 15 min to consume
the entire contents of the breakfast meal.Electrochemiluminescence
Quantitative assessments of GLP17–36 (pg/ml), glucagon
(pg/ml), leptin (pg/ml) and insulin (pmol/l) were simul-
taneously determined in duplicate in 40 ml of plasma by
electrochemiluminescence using a human hormone
multiplex assay kit (Sector Imager 2400, MesoScaleThis work is licensed under a Creative Commons
Attribution 3.0 Unported License.
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4–10 3 :236Discovery, Rockville, MD, USA). To facilitate quantifi-
cation, a standard curve was produced from a stock
calibrator of known hormone concentration. The stock
calibrator was provided by the manufacturer and diluted
(fourfold serial dilutions) accordingly to generate an eight-
point standard curve with a supplied ‘Metabolic Assay
Working Solution’. As per manufacturer’s instructions, the
calibrators were analysed in duplicate and included for
each set of unknown samples and on each assay plate.
Using linear regression analysis, linearity and the quality
of the curve-fit corresponded to r2R0.95 for all peptides
and across all assays. The lower limit of detection
(sensitivity) for GLP17–36, glucagon, leptin and insulin
was 0.7G0.2 pg/ml, 58.4G9.2 pg/ml, 101.6G6.8 pg/ml
and 2.0G1.2 pmol/l respectively, as determined from an
in-house analysis. The concentrations below the detection
limit were left blank, yet accounted for within the time-
averaged area under the curve (AUC) calculation.
To eliminate inter-assay variation, samples from each
participant were analysed within the same run. In part 1,
average intra-assay coefficients of variation (CV) were 12,
7, 15, and 12% for GLP17–36, glucagon, leptin and insulin
respectively. For part 2, average intra-assay CV were 10, 8,
6, and 12% for GLP17–36, glucagon, leptin and insulin
respectively. Intra-assay CV were determined for part 1
by the repeated measurement of a single-baseline
antecubital-venous plasma sample five times. For part 2,
intra-assay CV were determined by the repeated measure-
ment of a single-baseline fingertip-capillary plasma sample
three times (primarily due to the reduced volume of
plasma available for analysis).Statistical analyses
Descriptive data are presented as meansGS.D. The time-
averaged AUC score was computed for each peptide,
in antecubital-venous and fingertip-capillary blood,
using the trapezoidal rule. Agreement between fingertip-
capillary and antecubital-venous-derived measurements
was subsequently assessed using Deming regression
(to test for systematic and proportional bias) (17), Bland–
Altman (18) limits of agreement (LOA; to quantify random
error), and typical error of the estimate as a CV (CVa) (%)
to compare random error between measures (19). Assump-
tions of normal distribution and non-dependence of
measurements were assessed using boxplots and scatter
plots respectively (20). For Deming regression, systematic
and proportional bias was evaluated by means of the
intercept and slope respectively (21). For LOA,
heteroscedasticity was assessed by inspecting scatterhttp://www.endocrineconnections.org
DOI: 10.1530/EC-14-0110
 2014 The authors
Published by Bioscientifica Ltdplots and associated Pearson’s correlation coefficients of
the absolute differences (errors) and measurement means
(18). Where significant heteroscedasticity existed (defined
as an r value O0.4), data were log transformed (natural)
and reported as a geometric mean and ratio (!/O) LOA.
Statistical significance was accepted at P!0.05 for all
analyses. Between-day test–retest reproducibility of
fingertip-capillary measures was assessed using paired-
samples t-tests and typical error as a CV (CVr) (%).
For the purpose of this study, pre-determined clini-
cally significant differences were computed for each
peptide before data collection. Differences employed
were facilitated through literature-informed choices and
their associated effects on subjective appetite, feeding
behaviour and within-subject day-to-day biological
variation. For plasma concentrations of GLP17–36 and
glucagon, pre-determined time-averaged AUC differences
of 1.4 pg/ml per h (2) and 4.9 pg/ml per h (22), between
methodological approaches and visits were deemed
clinically important discrepancies respectively. Further-
more, differences of 62.0 pmol/l per h (23) and
148.0 pg/ml per h (24) were deemed clinically important
for plasma concentrations of insulin and leptin between
methodological approaches and visits respectively.
Furthermore, based on the within-subject variation of
antecubital-venous plasma glucagon (19% (25)), leptin
(20% (24)) and insulin (26% (25)), typical error of the
estimate when reported as a CV% was deemed strong
when below 10%, modest when equal or similar to
previously reported variation, and poor when substan-
tially greater than this.Results
In total, 19 participants completed the agreement study.
However, due to difficulties associated with cannulation
and consequently blood collection, results for GLP17–36,
glucagon and insulin are presented for 17 subjects, and
16 subjects for leptin. All 18 participants successfully
completed the between-day reproducibility study and the
results for GLP17–36, glucagon and insulin are provided. For
leptin, however, results are available from 17 subjects. One
participant’s data were excluded on the basis of yielding a
time-averaged AUC value of 3 S.D.s above the group mean.Agreement between antecubital-venous and fingertip-
capillary-derived peptide hormones
Deming regression analysis revealed no evidence of
systematic (intercept (95% CI)ZK5.8 (K31.0 to 19.5)) orThis work is licensed under a Creative Commons
Attribution 3.0 Unported License.
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Figure 1
(A) Comparison of plasma glucagon (pg m/l) measures obtained simul-
taneously from fingertip-capillary and antecubital-venous blood samples
(left). Deming regression scatter plot (right). The solid line represents
the line of equality. The dashed line denotes the regression line
with corresponding 95% CIs represented in the grey hashed area.
(B) Comparison of plasma glucagon-like peptide- 1 (GLP17–36) (pg m/l)
obtained from simultaneous fingertip-capillary and antecubital-venous
blood samples (left). Deming regression scatter plot (right). The solid line
represents the line of equality. The dashed line denotes the regression line
with corresponding 95% CIs represented in the grey hashed area. All values
are expressed as meanGS.E.M. Grey shaded boxes represent values obtained
from fingertip-capillary blood sampling, whereas black shaded boxes
represent concentrations in antecubital-venous blood. To convert GLP17–36
(pg m/l) and plasma glucagon (pg m/l) to their corresponding SI units
multiply values by 0.298 and 0.287 respectively.
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5–10 3 :237proportional bias (slope (95% CI)Z1.1 (0.8–1.3)) between
antecubital-venous (meanGS.D., 90.1G23.8 pg/ml per h)
and fingertip-capillary (90.0G37.2 pg/ml per h) time-
averaged AUC estimates of plasma glucagon (Fig. 1A).
Similarly, Deming regression analysis of fingertip-capillary
and antecubital-venous measures of plasma GLP17–36
(meanGS.D., 8.6G3.4 pg/ml per h vs 9.1G3.0 pg/ml per h
respectively, Fig. 1B) and leptin (meanGS.D., 664.5G
350.3 pg/ml per h vs 741.0G375.2 pg/ml per h respec-
tively, Fig. 2A) demonstrated no evidence of systematic
or proportional bias between methodological approaches.
For insulin, Deming regression revealed no evidence of
systematic bias (intercept (95% CI)ZK28.4 (K106.8 to
50.1)) between antecubital-venous (meanGS.D., 302.4G
154.7 pmol/l per h) and fingertip-capillary (meanGS.D.,
236.2G113.0 pmol/l per h) blood sampling; however,
there was a proportional difference between measure-
ments at higher concentrations (slope (95% CI)Z1.4
(1.1 to 1.7, intercept (95% CI)ZK28.4 (K106.8 to
50.1), Fig. 2B).http://www.endocrineconnections.org
DOI: 10.1530/EC-14-0110
 2014 The authors
Published by Bioscientifica LtdAgreement between fingertip-capillary and antecubital-
venous-derived measures of glucagon (CVaZ21.0%, LOAG
31.5 pg/ml per h, Fig. 1A) was good and modest for GLP17–36
(CVaZ24.0%, LOA G2.5 pg/ml per h, Fig. 1B) and
leptin (CVaZ9.0%, LOA !/O 1.19, Fig. 2A). For insulin,
although the pattern of response to the standardised
meal was similar, agreement between fingertip-capillary
and antecubital-venous estimates was poor (CVaZ36.0%,
LOA!/O1.79, Fig. 2B).Between-day reproducibility of fingertip-capillary-
derived peptide hormones
No systematic bias existed for time-averaged AUC
measurement of any fingertip-capillary-derived peptides
between visits (PR0.05 for all). Reproducibility of plasma
glucagon was strong between visits (meanGS.D.,
103.3G36.9 pg/ml per h vs 103.6G32.9 pg/ml per h,
CVrZ8.2%, Fig. 3B). Plasma GLP17–36 (8.6G3.2 pg/ml
per h vs 8.8G3.0 pg/ml per h, Fig. 3A) and leptinThis work is licensed under a Creative Commons
Attribution 3.0 Unported License.
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Figure 2
(A) Comparison of plasma leptin (pg m/l) measures obtained simul-
taneously from fingertip-capillary and antecubital-venous blood samples
(left). Deming regression scatter plot (right). The solid line represents
the line of equality. The dashed line denotes the regression line
with corresponding 95% CIs represented in the grey hashed area.
(B) Comparison of plasma insulin (pmol/l) obtained from simultaneous
fingertip-capillary and antecubital-venous blood samples (left).
Deming regression scatter plot (right). The solid line represents the line of
equality. The dashed line denotes the regression line with corresponding
95% CIs represented in the grey hashed area. All values are expressed as
meanGS.E.M. Grey shaded boxes represent values obtained from fingertip-
capillary blood sampling, whereas shaded boxes represent concentrations
in antecubital-venous blood.
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6–10 3 :238(3870.8G3482.7 pg/ml per h vs 3774.9G3813.3 pg/ml
per h, Fig. 3C) demonstrated modest reproducibility
(CVrZ22.7 and 25.0% respectively). Plasma insulin
exhibited the greatest variability (291.7G142.1 pmol/l
per h vs 253.9G94.7 pmol/l per h, CVrZ36.0%, Fig. 3D),
indicating a large degree of random error between visits.Discussion
This study is the first to examine the agreement between
fingertip-capillary and antecubital-venous blood sampling
for the determination of plasma GLP17–36, glucagon,
insulin and leptin, and the between-day reproducibility
of these hormonal peptides measured utilising
fingertip-capillary blood. The results presented here
support the use of fingertip-capillary-derived estimates of
glucagon, and to a lesser extent for GLP17–36 and leptin.
Caution should be exercised when utilising fingertip-
capillary blood sampling for insulin quantification. The
presence of proportional bias between fingertip-capillary
and antecubital-venous estimates of insulin suggests these
methods should not be employed interchangeably.http://www.endocrineconnections.org
DOI: 10.1530/EC-14-0110
 2014 The authors
Published by Bioscientifica LtdThese results have important implications for researchers
and practitioners who wish to quantify the expression of
these appetite- and metabolism-related peptides in various
populations or field-based scenarios where antecubital-
venous blood sampling might be contraindicated.
Furthermore, fingertip-capillary blood sampling offers
many advantages including simplistic application, cost/
time effectiveness and reduced volume of blood required
for analysis (6).
In this study, plasma glucagon and GLP17–36
illustrated no evidence of systematic or proportional bias
between methodological approaches, and no systematic
bias was detected for between-day fingertip-capillary
sampling, suggesting fasting and postprandial concen-
trations of these peptides are comparable between
methodological approaches (Fig. 1) and reproducible
between visits (Fig. 3). These observations coupled with
the overall bias generated between fingertip-capillary and
antecubital-venous time-averaged AUC for glucagon
(K0.2 pg/ml per h) and GLP17–36 (0.4 pg/ml per h) and
between-day fingertip-capillary sampling (0.3 pg/ml per h
and 0.2 pg/ml per h respectively) were not deemedThis work is licensed under a Creative Commons
Attribution 3.0 Unported License.
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Figure 3
(A) Comparison of fingertip-capillary-derived measures of plasma
GLP17–36 (pg m/l) between days. (B) Comparison of plasma glucagon
(pg m/l) between days. (C) Comparison of plasma leptin (pg m/l) between
days. (D) Comparison of plasma insulin (pmol/l) between days. All values
are expressed as meanGS.E.M. Grey shaded boxes represent values obtained
from fingertip-capillary blood during visit 1, whereas shaded boxes
represent concentrations in fingertip-capillary blood during visit 2.
To convert GLP17–36 (pg m/l), plasma glucagon (pg m/l) to their
corresponding SI units multiply values by 0.298 and 0.287 respectively.
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7–10 3 :239clinically relevant discrepancies as based on our
pre-determined values (4.9 pg/ml per h (22) and
1.4 pg/ml per h (2) respectively). Between methodological
approaches, the typical percentage error (CVa) (%) of
plasma glucagon and GLP17–36 was similar (CVaZ21.0 and
24.0% respectively), demonstrating modest agreement.
Under test–rest conditions, fingertip-capillary-derived
estimates of glucagon displayed strong reproducibility
with an acceptable level of random error (CVrZ8.2%), yet
remained similar for plasma GLP17–36 (CVrZ22.7%). The
results concerning plasma glucagon are considerably
lower than the biological variation presented by Widjaja
et al. (25). Widjaja et al. (25) assessed the variation (within-
and between-subject variation over 12 consecutive days)
of several biochemical variables in healthy adults, and
illustrated that antecubital-venous plasma glucagon
exerted a daily variation of 19.0 and 28.0% within- and
between-subjects respectively (25). Results of the current
study may therefore suggest that estimates of fingertip-
capillary plasma glucagon are comparable with their
antecubital-venous equivalents, and more reliable when
obtained within fingertip-capillary blood. To the authors’
knowledge, this is the first study to report the test–retest
reproducibility of plasma GLP17–36. GLP1 is producedhttp://www.endocrineconnections.org
DOI: 10.1530/EC-14-0110
 2014 The authors
Published by Bioscientifica Ltdand secreted into the circulation from the L cells of the
intestinal mucosa in response to meal ingestion, and is
recognised as a key effector in glucose regulation,
gastrointestinal motility and appetite (26, 27). In this
study, plasma GLP17–36 demonstrated moderate CV values
with negligible bias between methodological approaches
and days. Similar to plasma glucagon, results of the
current study may suggest that estimates of GLP17–36 are
more reliable when obtained within fingertip-capillary
blood. Nonetheless, further research quantifying the
biological variation of GLP17–36 is warranted to elucidate
the within- and between-subject variation of this peptide.
Taken together, fingertip-capillary blood sampling pro-
vides reliable and comparable measures of glucagon and
GLP17–36 with antecubital-venous samples, indicating the
two methodological approaches may be interchanged.
These results are of importance as they permit comparison
of results obtained in studies utilising fingertip-capillary
blood sampling with studies using antecubital venous
blood sampling.
Although Deming regression revealed no evidence of
systematic or proportional bias between methodological
approaches (Fig. 2A), and no systematic bias for
between-day fingertip-capillary sampling, estimates ofThis work is licensed under a Creative Commons
Attribution 3.0 Unported License.
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underestimated in comparison with their antecubital-
venous equivalents. It might be unsurprising that the
concentrations of leptin differed between methodological
approaches given its production site, manner of collection
and differing sampling location. Leptin is predominantly
secreted from the adipose tissue (28), whereas all other
hormones analysed within this study are secreted from
either the pancreas or the gastrointestinal tract. The
antecubital vein drains a mixture of forearm muscle,
adipose and skin tissues (29), compared with the fingertip,
which drains an assortment of blood from venules,
arterioles, intracellular and interstitial fluid, and of
course the capillaries. The concentrations of plasma leptin
may therefore be more pronounced in venous outflow,
as illustrated in this study. Despite this tendency, the
biases generated between methodological approaches
(K77.5 pg/ml per h, CVaZ9.0%) and between days
(95.9 pg/ml per h) were not deemed clinically relevant
discrepancies and likely to alter research interpretation
based on our pre-determined values (148.0 pg/ml per h),
which takes into account the within-subject daily
variation of plasma leptin (24). Under test–reset con-
ditions, fingertip-capillary-derived estimates of leptin
demonstrated modest reproducibility, with a satisfactory
typical percentage error (CVrZ25.0%). Leptin, a tonic
adipocyte hormone, indicates long-term energy balance
(30, 31) and signals chronic nutritional state. It may be
plausible that the increased bias and level of typical error
between days may be attributable to dietary standardi-
sation. In this study, dietary standardisation was only
implemented from the evening meal preceding data
collection periods. Standardisation to promote identical
nutritional states may therefore require longer dietary
replication. Nonetheless, the typical error reported
between days was similar to that reported in earlier
investigations (24, 32). These researchers established the
reproducibility of fasting plasma leptin among lean and
obese individuals in antecubital-venous blood, and pro-
vided evidence that plasma leptin exerts a daily variation of
20% (24). Based on the typical percentage error, we report
that fingertip-capillary blood sampling is an acceptable
approach for leptin quantification, but should not be
interchanged with antecubital-venous blood sampling.
For insulin quantification, Deming regression revealed
evidence of proportional difference between fingertip-
capillary and antecubital-venous blood (slopeZ1.4, 95%
CI for slopeZ1.1 to 1.7, 95% CI for interceptZK106.8 to
50.1), and visual inspection of scatter plots indicated
worse agreement between measurements at higherhttp://www.endocrineconnections.org
DOI: 10.1530/EC-14-0110
 2014 The authors
Published by Bioscientifica Ltdconcentrations (Fig. 2B). The identification of proportional
bias between fingertip-capillary and antecubital-venous
blood sampling illustrates that these techniques cannot
be used interchangeably. The typical percentage error of
plasma insulin was similar between methodological
approaches and between visits (CVa and CVrZ36.0%
respectively), representing a large level of random error.
The CV values demonstrated here are higher than the
within-subject variation of plasma insulin (26%) as
illustrated by Widjaja et al. (25). Despite this, the bias
generated between days (K37.8 pmol/l per h) was not
deemed a clinically relevant discrepancy according to our
pre-determined values (62.0 pmol/l per h), which took
into account the within-subject daily variation of plasma
insulin. Nonetheless, compared with antecubital-venous
blood, Deming regression, typical percentage error and
LOA suggest that fingertip-capillary represents an inap-
propriate alternative for insulin quantification. Perhaps
fingertip-capillary blood, being arterialised, is comparable
and more reflective of arterial-derived estimates. Further
work to elucidate this is necessary. Researchers and
practitioners wishing to implement this technique
should take the random error between techniques into
consideration when interpreting study findings.
No data concerning differences in any of the peptides
reported here based on antecubital-venous and fingertip-
capillary blood sampling exist. The error observed
(differences observed for each analyte between methodo-
logical approaches and between visits) may be attributable
to pre-analytical (e.g. specimen collection, timing of
collection) and analytical error (e.g. collection techniques,
sample handling). As mentioned, blood attained
following fingertip-capillary blood sampling is charac-
teristically dissimilar to that of antecubital-venous blood,
and may be more reflective of arterial blood (12).
Furthermore, discrepancies between fingertip-capillary
and antecubital-venous-derived peptides might have
been influenced by the introduction of cytoplasmic matter
(intracellular fluid) to the fingertip-capillary sample.
Excessive squeezing during fingertip-capillary blood
sampling encourages haemolysis of the erythrocytes,
thus influencing the introduction of intracellular contents
to the surrounding blood plasma consequently diluting
samples and affecting assay effectiveness (33). In this
study, highly trained research staff collected all fingertip-
capillary blood samples and care was taken to avoid
excessive pressure whilst sampling in an attempt to
minimise the risk of such error.
This study provides valuable information for
researchers and practitioners regarding the utility ofThis work is licensed under a Creative Commons
Attribution 3.0 Unported License.
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appetite- and metabolism-regulating peptides. Caution
should be observed when extrapolating the results of this
study, as the findings might be limited to relatively short
durations (2 h) and a healthy adult population. Further
research is required to quantify the agreement for longer
duration sedentary periods, in other situational states and
alternative populations. It is of great importance to note
that the results presented here can only be assumed for
samples taken as EDTA plasma with the respective additives
(aprotinin (33 ml/ml blood) and a di-peptidyl peptidase IV
inhibitor (30 ml/ml blood)). Furthermore, the authors’
acknowledge that values for CV% in the current study
appear relatively high, particularly for GLP17–36 and leptin,
yet are consistent with the variability expected between
plasma samples from the same sampling location. For this
reason, the findings of this study suggest that fingertip-
capillary blood sampling represents a suitable and
comparable alternative to antecubital-venous methods for
the estimation of certain appetite-related peptides.
In conclusion, this study demonstrates that at rest
fingertip-capillary blood sampling offers an appropriate
methodological and reproducible approach for the
quantification of glucagon and to a lesser extent for
GLP17–36 and leptin. Caution should be exercised when
using fingertip-capillary sampling for plasma insulin
quantification in repeated measures designs, and should
not be interchanged with antecubital-venous blood
sampling. These findings will allow for appropriate
comparison of capillary and venous sampling techniques
in the fields of appetite and metabolism, where fingertip-
capillary sampling might offer a more appropriate
approach (e.g. paediatrics, adolescents and elderly).Declaration of interest
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